ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

1.78
0.33
(22.76%)
Closed April 22 3:00PM
1.85
0.07
( 3.93% )
Pre Market: 7:06AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 4.71M2.4M4.75M3.6M3.41M1.11M1.79M2.02M
Operating Income -16.56M-23.38M-15.63M-15.8M-24.33M-21.3M-21.06M-19.93M
Pre Tax Income -17.62M-24.6M-117.09M47.74M-24.06M-20.93M-25.52M-18.79M
Net Income -17.62M-24.6M-117.09M47.74M-24.06M-20.93M-25.52M-18.79M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -16.57M-23.38M-15.65M-15.82M-24.34M-21.26M-21.14M-20M
EBITDA -16.23M-23.04M-15.3M-15.43M-24.01M-20.98M-20.77M-19.63M
Year End December 30 2024 201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0002.5M15.45M8.33M
Operating Income -1.12M-43M-173.27M-126.03M-71.37M-86.62M
Pre Tax Income -1.12M-60.01M-174.52M-166.01M-111.57M-89.3M
Net Income -1.12M-60.01M-174.52M-166.01M-111.57M-89.3M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.102-1.589-4.536-2.626-0.597-0.436
EBIT -1.12M-43M-173.27M-126.05M-71.42M-86.73M
EBITDA -1.12M-42.99M-172.78M-124.86M-70M-85.38M